“…One of them reported no significant change after de novo plaque accumulation [25]. Thirteen studies showed higher levels of IL-1β in PICF than healthy implant sites [7,21,22,30,35,36,41-47]. Of the 10 studies assessed TNF-α, 3 of them showed no relationship with this cytokine with peri-implant inflammation [7,25,43], while other 7 studies showed significant relationship with this cytokine [23,24,36,41,46-48].…”